EUVIMEDEUVIMED entdecken
Leserbrief

Signal Worth Trusting—If We Can Reproduce It: Clarifying Overall Response Rate and Progression-Free Survival in BEACON Immuno

Yongkai Lu

Journal of Clinical Oncology · 20.06.2026 · 44 (18) · 1745-1746

DOI: 10.1200/jco-25-03015 ↗

Kurz gefasst

Leserbrief in der Zeitschrift Journal of Clinical Oncology, erschienen am 20.06.2026. Verfasst von Yongkai Lu. Beteiligte Einrichtung: Yongkai Lu, MD, Department of Radiation Oncology, The First Affiliated Hospital of Xi'an Jiaotong University, Shaanxi, China. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 4 Literaturangaben.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Autor:innen und Institutionen

  • Yongkai Lu, MD, Department of Radiation Oncology, The First Affiliated Hospital of Xi'an Jiaotong University, Shaanxi, China.

Zitieren

APA

Lu, Y. (2026). Signal Worth Trusting—If We Can Reproduce It: Clarifying Overall Response Rate and Progression-Free Survival in BEACON Immuno. Journal of Clinical Oncology, 44(18), 1745-1746. https://doi.org/10.1200/jco-25-03015

Vancouver

Lu Y. Signal Worth Trusting—If We Can Reproduce It: Clarifying Overall Response Rate and Progression-Free Survival in BEACON Immuno. Journal of Clinical Oncology. 2026;44(18):1745-1746. doi:10.1200/jco-25-03015

BibTeX
@article{Lu2026,
  author = {Lu, Yongkai},
  title = {Signal Worth Trusting—If We Can Reproduce It: Clarifying Overall Response Rate and Progression-Free Survival in BEACON Immuno},
  journal = {Journal of Clinical Oncology},
  year = {2026},
  volume = {44},
  number = {18},
  pages = {1745--1746},
  doi = {10.1200/jco-25-03015}
}
Kostenlos starten →